R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Clinical trial NCT05345158 · RECRUITING
Trial details
- NCT number
- NCT05345158
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2030-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.